Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Bullboard Posts
Comment by Howitzer8on May 22, 2020 12:32pm
67 Views
Post# 31061403

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Take a look at “MIR”

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Take a look at “MIR”MIR is way better off in the COVID area due to the fact that they manufacture tests, have started receiving approvals. The fact that SZLS is just going to process tests and everything has to funnel through one lab is not ideal although there will be some nice numbers there if they can get anywhere near their capacity. In the long run MIR doesn't have much and SZLS has the world at its finger tips. Tripp is an abomination and even with a gem of a product like aristotle he can blunder it. Fingers crossed that he doesn't.

This is how adults reason young fella. Conspiricy theories about multiple accounts and "manipulating" people is childish talk.
Bullboard Posts